chartexchange

CMPS
COMPASS Pathways Plc
stockNASDAQADR

At CloseNov 18, 2026 3:59:58 PM EST
8.12USD+1.754%(+0.14)2,354,927
Pre-marketNov 18, 2026 9:22:30 AM EST
8.00USD+0.251%(+0.02)
After-hoursNov 18, 2026 4:56:30 PM EST
8.00USD-1.478%(-0.12)
Loading…
Loading…
Healthcare
Medical Care Facilities
HQ
London, United Kingdom
Previous Close
$7.98
Beta
1.86
52-Week High
$15.87 2026-09-09
52-Week Low
$4.88 2026-03-24
SMA 50
$11.67
SMA 200
$10.50
Avg. Vol 10D
3.43M
Avg. Vol 30D
3.35M
Avg. Vol 90D
3.15M
Relative Vol
0.70
141.71M
139.40M
17,201,909
0.4100%
4,100,000
170
CMPS Profile

compass pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. our first major initiative is developing psilocybin therapy through late-stage clinical trials in the eu and us for patients with treatment-resistant depression. we are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

CMPS Performance
PeriodPriceDateChangeBeta
1W9.302026-11-11-12.69%4.219
1M11.112026-10-19-26.91%2.690
3M13.902026-08-18-41.58%2.424
6M10.562026-05-18-23.11%1.882
1Y5.392025-11-18+50.65%1.861
2Y4.662024-11-18+74.25%—
5Y31.292021-11-18-74.05%1.450
CMPS Stock Summary

COMPASS Pathways Plc (NASDAQ:CMPS) stock price today is $8.12, and today's volume is 2,354,927. CMPS is up 1.754% today. The 30 day average volume is 3.35M. CMPS market cap is $1.15B with 141.71M shares outstanding.